Drug allergy laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 21: | Line 21: | ||
*[[Intradermal]] tests – these tests involve the injection of a small amount of allergen under the skin, into the dermis. [[Intradermal]] testing with delayed readout is more sensitive than a patch test, but carries a slightly higher risk of adverse allergic reactions when compared to skin testing. It tests for the same compounds as a skin prick test, and also leads to the diagnosis of IgE mediated hypersensitivity reactions. A prick test should be done beforehand, and the concentration used should be non-irritating. | *[[Intradermal]] tests – these tests involve the injection of a small amount of allergen under the skin, into the dermis. [[Intradermal]] testing with delayed readout is more sensitive than a patch test, but carries a slightly higher risk of adverse allergic reactions when compared to skin testing. It tests for the same compounds as a skin prick test, and also leads to the diagnosis of IgE mediated hypersensitivity reactions. A prick test should be done beforehand, and the concentration used should be non-irritating. | ||
* [[In-vitro]] tests for immediate drug reactions are available, but are largely considered investigational. | * [[In-vitro]] tests for immediate drug reactions are available, but are largely considered investigational. | ||
*Patch testing – this type of testing is useful for the diagnosis of various delayed type IV [[cutaneous]] reactions such as [[exanthemata]], acute generalized exanthematous pustulosis, and flexular exanthema. It involves placing an aluminum disc containing allergens mixed with petrolatum on a patient’s back for 48 hours. The patient is then assessed for any reactions that may have occurred. This type of testing is not helpful to the diagnosis of [[Stevens-Johnson syndrome]] or [[toxic epidermal necrolysis]] and is contraindicated in anyone with a history of these conditions. | *Patch testing – this type of testing is useful for the diagnosis of various delayed type IV [[cutaneous]] reactions such as [[exanthemata]], acute generalized exanthematous pustulosis, and flexular exanthema. It involves placing an aluminum disc containing allergens mixed with petrolatum on a patient’s back for 48 hours. The patient is then assessed for any reactions that may have occurred. This type of testing is not helpful to the diagnosis of [[Stevens-Johnson syndrome]] or [[toxic epidermal necrolysis]] and is contraindicated in anyone with a history of these conditions. <ref name="pmid20485160">{{cite journal| author=Friedmann PS, Ardern-Jones M| title=Patch testing in drug allergy. | journal=Curr Opin Allergy Clin Immunol | year= 2010 | volume= 10 | issue= 4 | pages= 291-6 | pmid=20485160 | doi=10.1097/ACI.0b013e32833aa54d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20485160 }} </ref> | ||
*[[Skin biopsy]] may be useful to distinguish between Stevens-johnson syndrome and toxic epidermal necrolysis, and also to rule out other conditions on the differential diagnosis list. | *[[Skin biopsy]] may be useful to distinguish between Stevens-johnson syndrome and toxic epidermal necrolysis, and also to rule out other conditions on the differential diagnosis list. | ||
*[[Histamine]] and [[tryptase]] levels- these test have shown to be useful in confirming the diagnosis of acute [[IgE]] mediated reactions, in particular [[anaphylaxis]]. Negative results do not rule out an anaphylactic reaction. | *[[Histamine]] and [[tryptase]] levels- these test have shown to be useful in confirming the diagnosis of acute [[IgE]] mediated reactions, in particular [[anaphylaxis]]. Negative results do not rule out an anaphylactic reaction. | ||
Revision as of 19:59, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
|
Drug Allergy |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Drug allergy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Drug allergy laboratory findings |
|
Risk calculators and risk factors for Drug allergy laboratory findings |
Overview
Drug allergy and its associated conditions is primarily a clinical diagnosis based on the patient history, and through physical exam. Certain laboratory findings may be seen during the acute phase of the reaction, but are not always specific. Skin testing and biopsies can be performed when there is not a clear diagnosis.
Laboratory Findings
- Erythrocyte sedimentation rate (ESR) may be increased.
- White blood cell (WBC) may be increased.
- Urine eosinophils may be increased, especially in cases of allergic interstitial nephritis.
- Blood eosinophils may be increased, especially in cases of drug induced TEN.
- Liver function tests (LFT)'s may be increased.
- Elevations in tryptase may be seen detected in serum or plasma within several hours after an acute allergic event, and is consistent with anaphylaxis.
- Histamine levels may be elevated after an acute reaction, but is unreliable for diagnosis.
Other Tests
- Skin testing- skin prick testing (SPT) pricks the skin with a tiny amount of the suspected allergen, and leads to the diagnosis of IgE mediated type I hypersensitivity reactions. These tests are standardized for penicillin, and are also useful for local anesthetics, muscle relaxants. These tests are also very sensitive for high-molecular-weight protein substances such as insulin and monoclonal antibodies. A negative test is useful for ruling out a penicillin allergy, however with other tests (except for with high-molecular-weight proteins), a negative test is not always useful for ruling out the presence of serum specific IgE. [1]
- Intradermal tests – these tests involve the injection of a small amount of allergen under the skin, into the dermis. Intradermal testing with delayed readout is more sensitive than a patch test, but carries a slightly higher risk of adverse allergic reactions when compared to skin testing. It tests for the same compounds as a skin prick test, and also leads to the diagnosis of IgE mediated hypersensitivity reactions. A prick test should be done beforehand, and the concentration used should be non-irritating.
- In-vitro tests for immediate drug reactions are available, but are largely considered investigational.
- Patch testing – this type of testing is useful for the diagnosis of various delayed type IV cutaneous reactions such as exanthemata, acute generalized exanthematous pustulosis, and flexular exanthema. It involves placing an aluminum disc containing allergens mixed with petrolatum on a patient’s back for 48 hours. The patient is then assessed for any reactions that may have occurred. This type of testing is not helpful to the diagnosis of Stevens-Johnson syndrome or toxic epidermal necrolysis and is contraindicated in anyone with a history of these conditions. [2]
- Skin biopsy may be useful to distinguish between Stevens-johnson syndrome and toxic epidermal necrolysis, and also to rule out other conditions on the differential diagnosis list.
- Histamine and tryptase levels- these test have shown to be useful in confirming the diagnosis of acute IgE mediated reactions, in particular anaphylaxis. Negative results do not rule out an anaphylactic reaction.
- Complete blood count – a complete blood count (CBC) is useful in ruling out hemolytic type II drug reactions, such as hemolytic anemia, thrombocytopenia or neutropenia.
- Coombs test- the indirect and direct Coomb’s test is used to determine the presence of antibodies on red cell membranes. This test can also be useful in confirming hemolytic anemia. [3]
- Basophil activation test- this test quantifies the activation of basophils using flow cytometry. Basophils are implicated in the development of both immune and non-immune mediated drug reactions. Some studies have shown that this test is useful in evaluating allergy towards beta-lactam antibiotics, muscle relaxants, and NSAIDS, however further studies are needed before this type of testing is widely accepted as a diagnostic tool. [4]
References
- ↑ Warrington R, Silviu-Dan F (2011). "Drug allergy". Allergy Asthma Clin Immunol. 7 Suppl 1: S10. doi:10.1186/1710-1492-7-S1-S10. PMC 3245433. PMID 22165859.
- ↑ Friedmann PS, Ardern-Jones M (2010). "Patch testing in drug allergy". Curr Opin Allergy Clin Immunol. 10 (4): 291–6. doi:10.1097/ACI.0b013e32833aa54d. PMID 20485160.
- ↑ Schnyder B (2009). "Approach to the patient with drug allergy". Immunol Allergy Clin North Am. 29 (3): 405–18. doi:10.1016/j.iac.2009.04.005. PMID 19563988.
- ↑ Hausmann OV, Gentinetta T, Bridts CH, Ebo DG (2009). "The basophil activation test in immediate-type drug allergy". Immunol Allergy Clin North Am. 29 (3): 555–66. doi:10.1016/j.iac.2009.04.011. PMID 19563997.